Cargando…
The Inositide Signaling Pathway As a Target for Treating Gastric Cancer and Colorectal Cancer
Gastric cancer and colorectal cancer are the leading cause of cancer mortality and have a dismal prognosis. The introduction of biological agents to treat these cancers has resulted in improved outcomes, and combination chemotherapy with targeted agents and conventional chemotherapeutic agents is re...
Autores principales: | Kim, Hong Jun, Lee, Suk-young, Oh, Sang Cheul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4861839/ https://www.ncbi.nlm.nih.gov/pubmed/27242542 http://dx.doi.org/10.3389/fphys.2016.00168 |
Ejemplares similares
-
Nuclear Inositides and Inositide-Dependent Signaling Pathways in Myelodysplastic Syndromes
por: Xian, Jie, et al.
Publicado: (2020) -
A structural basis for lithium and substrate binding of an inositide phosphatase
por: Dollins, D. Eric, et al.
Publicado: (2020) -
Advances of Targeted Therapy in Treatment of Unresectable Metastatic Colorectal Cancer
por: Lee, Suk-young, et al.
Publicado: (2016) -
Novel Systemic Therapies for Advanced Gastric Cancer
por: Kim, Hong Jun, et al.
Publicado: (2018) -
Genipin suppresses colorectal cancer cells by inhibiting the Sonic Hedgehog pathway
por: Kim, Bo Ram, et al.
Publicado: (2017)